EN1 and carcinoma: The high prevalence of methylation in EN1 CpG island (three out of every four carcinomas show hypermethylation of this gene) together with its possible functional role in cancer (Bachar-Dahan et al, 2006; Rauch et al, 2007) lead us to evaluate its putative clinical usefulness as a diagnostic marker of disease.